Strive, Inc.

Companies

Strive, Inc. (Nasdaq: ASST) is an asset management firm and Bitcoin treasury company co-founded by Vivek Ramaswamy. Formed through the 2025 merger of Strive Asset Management and Asset Entities, it was the first publicly traded asset management firm to adopt a Bitcoin treasury strategy. In January 2026, Strive acquired Semler Scientific, adding approximately 5,048 BTC to its treasury and rebranding under the ticker ASST. Strive also manages several ETFs including the Strive 500 ETF.

Details

Ceo: Matt Cole
Public: Yes
Sector: financial_services
Ticker: ASST
Category: Asset Management / Bitcoin Treasury
Exchange: NASDAQ
Founders: Vivek Ramaswamy, Anson Frericks
Market Cap: ~$1.5B (as of Q1 2026)
Bitcoin Only: No
Founded Year: 2023
Headquarters: Columbus, Ohio, USA
Acquisition Note: Acquired Semler Scientific (SMLR) on January 16, 2026, adding ~5,048 BTC. Now trades as ASST on Nasdaq.
Bitcoin Holdings: 13628
Bitcoin Strategy: Bitcoin-focused investment management; accumulated BTC from acquisitions including Semler Scientific merger
Btc Holdings Date: 2026-03
Bitcoin Holdings Date: 2026-03

Links

twitter

More Companies

Strategy (formerly MicroStrategy)

Strategy (Nasdaq: MSTR), formerly MicroStrategy, is the world's largest corporate Bitcoin holder. Founded by Michael Saylor, the company rebranded in 2025 to reflect its identity as a Bitcoin treasury company. It holds over 500,000 BTC accumulated through equity and debt financing, pioneering the corporate Bitcoin standard that inspired hundreds of companies worldwide.

ACINQ

ACINQ is a French Bitcoin infrastructure company and the developer of Eclair, one of the three major Lightning Network implementations. Founded in 2014, ACINQ builds Phoenix Wallet (a non-custodial Lightning wallet) and operates the ACINQ Lightning node, one of the most well-connected nodes on the Lightning Network.

Acurx Pharmaceuticals

Acurx Pharmaceuticals (NASDAQ: ACXP) is a US biopharmaceutical company that made headlines in November 2021 by adopting Bitcoin as its primary treasury reserve asset — one of the first pharmaceutical companies to do so. The company approved purchasing $1 million in Bitcoin and has continued to hold BTC alongside its drug development pipeline focused on antibiotics. Notable for crossing industry boundaries to embrace the Bitcoin standard.